Bioprocess Pharmaceutical Filtration

A Case Study for Collaborative Filter Product Development

PROPOR HCParker domnick hunter is committed to increasing productivity and customer satisfaction through application-driven new product development, and collaboration is a highly effective way in which to achieve this.

 

The development of the PROPOR HC – a high capacity sterilizing-grade PES filter – shows just what can be achieved through partnership.

 

PROPOR HC was developed by Parker domnick hunter in conjunction with a multinational insulin manufacturer, which was experiencing premature filter blockage when filtering a product intermediate.

 

The challenge

The intermediate was being manufactured via a microbial fermentation. Downstream processing of the product involved multiple crystallization steps, which in some cases produced an intermediate that proved extremely difficult to filter.

 

It became impossible to guarantee that a batch of product could be processed through the existing sterile filtration stage. This led to a need to accommodate change out of filters mid-batch or having to quarantine a complete batch.

 

The cause of the filtration variability was identified as the production of small fibrils during the crystallization stages. While analysis of the final product showed that the fibrils did not affect the drug quality, the processing difficulties were substantially impacting on shipments and revenues.

 

Developing a solution

A team from Parker domnick hunter worked with the manufacturer to identify the cause of the problem and develop solutions that were used on a production scale.

 

The process:

  • Samples of problematic batches tested in conjunction with the customer at Parker domnick hunter laboratories
  • Product re-constituted using customer’s protocol
  • Small-scale filterability studies conducted to ascertain the optimum filtration train and membrane configuration
  • Evaluation of Parker domnick hunter’s highly asymmetric membranes (specifically designed to maximize throughputs on complex protein solutions)
  • Studies showed performance advantages of dual layer construction incorporating a prefilter and a sterilizing grade membrane
  • Evaluation of the most appropriate filtration solution against the existing system – the Parker domnick hunter dual layer product (PROPOR HC) showed dramatic improvement compared with the previously used single layer PVDF membrane filter

 

The performance advantages were achieved by the combination of expert optimization and the use of our new range of PES membranes, which combine a highly asymmetric structure with a very well controlled retentive layer on the downstream face of the membrane. Compared to other membranes, this provides substantially increased dirt holding capacity and flow rates, coupled with absolute microbial retention characteristics.

 

Asymmetric Membrane SEMs

 

 

 

The filterability studies conducted were invaluable in ensuring the filter configuration was optimized. The dual layer membrane construction incorporating a highly asymmetric prefilter layer has been shown to increase throughputs of proteinaceous solutions by up to ten times.

 

The significant benefits have also been realised with other protein based solutions such as serum free CHO-K1 medium and a 0.5 mg / ml protein concentration of dust mite serum. In both cases, system size was reduced more than 4 fold.

 

The efficacy of the membrane prefilter also allows the possibility of simplifying filter trains by replacing a discrete prefilter stage, thus providing further benefits.

 

Results

By involving the customer directly in product development, we ensured that the filter solved the customer’s problem: the use of PROPOR HC, means that the costly requirement to reprocess batches due to filtration difficulties was eliminated.

 

Plus, it took just six months for this process to reach a successful conclusion, from the initial filterability trials to on-site tests and full product validation. This forms an excellent example of the benefits of collaboration. 

 

Related blog posts

What is Sterilizing Filtration and Why is it Important?

How to Select the Right Filter for Your Bioprocess

 

 

This post was contributed by Andrew Kelly, Filtration Product Manager (Life Sciences), Parker domnick hunter Process Filtration, UK.

Email: dhprocessinfo@parker.com

 

Read the full application note Optimized Sterile Filtration of Pharmaceutical Solutions

 

 

 

Parker domnick hunter, specializes in automating and controlling single-use processes. By integrating sensory and automation technology into a process, a manufacturer can control the fluid flow more effectively, ensuring the quality of the final product. Find out more

 

Categories
Recent Posts by Author

Automating and Enclosing Bulk Fill Operations - the Way Forward?

The consequences of failure during downstream processing are severe. Following the Affinity Chromatography stage, the value of the product increases significantly at every step. A failure at the final...

Mycoplasma Contamination: Understanding the Risks and Taking on the Challenges

Mycoplasma contamination events, although rare, can have an enormous and immediate negative impact on biomanufacturers leading to reduced productivity and delays in products reaching patients. Parker...

The Biopharmaceutical Industry's Definition of Integrity

One of the challenges faced in any biopharmaceutical process is bioburden control and containment — or how do you keep what is out, "out" and what is in "in". For a stainless steel-based manufacturing...
Comments

Have a question about Parker products or services? We can help: Contact Us!

Comments for A Case Study for Collaborative Filter Product Development


Please note that, in an effort to combat spam, comments with hyperlinks will not be published.

Leave a comment





Captcha